Last Chance: Get 30 Days of MarketBeat All Access for FREE, then just $399 $199 for the year.
Start free trial
  •  days
  •  Hours
  •  Minutes
  •  Seconds
×
EXTENDED - TODAY ONLY: MarketBeat All Access For Just $399 $199 (save 50%)
Special Offer: Just $199
×
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
S&P 500   3,963.94
DOW   33,849.46
QQQ   282.71
Wall Street slips as lockdown protests spread in China
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
China virus protests hit Hong Kong after mainland rallies
Is Snowflake Poised for A Rebound After Its Recent Tumble?
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Need To Cut Costs? Start With These 10 Money Saving Ideas
Check Into The Hotel Rebound With These Welcoming Stocks
The Humble Mineral at the Heart of the EV Revolution (Not Lithium) (Ad)
Impeachment talk at Trump Org. trial: Did witness misspeak?
'Gaslighting' is Merriam-Webster's word of the year for 2022
NASDAQ:ADGI

Adagio Therapeutics - ADGI Earnings Date, Estimates & Call Transcripts

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
N/A
50-Day Range
$3.40
▼
$4.78
52-Week Range
N/A
Volume
22,357 shs
Average Volume
2.27 million shs
Market Capitalization
$504.98 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.00
Skip Charts & View Estimated and Actual Earnings Data
Earnings Per ShareRevenue

ADGI Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

ADGI Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Adagio Therapeutics Analyst Forecasts

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20221($0.75)($0.75)($0.75)
Q2 20221($0.54)($0.54)($0.54)
Q3 20221($0.52)($0.52)($0.52)
Q4 20221($0.56)($0.56)($0.56)
FY 20224($2.37)($2.37)($2.37)

Adagio Therapeutics Earnings History by Quarter

Export to Excel
DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
8/15/2022Q2 2022($0.55)($0.47)+$0.08($0.47)
5/13/2022Q1 2022($0.63)($0.93)($0.30)($0.93)
3/31/2022Q4 2021($0.77)($0.77)($0.77)
11/14/20219/30/2021($0.74)($0.98)($0.24)($0.98)
9/19/20216/30/2021($0.80)($0.18)+$0.62($0.18)












Adagio Therapeutics Earnings - Frequently Asked Questions

How much profit does Adagio Therapeutics generate each year?

Adagio Therapeutics (NASDAQ:ADGI) has a recorded net income of -$226.79 million. ADGI has generated -$3.15 earnings per share over the last four quarters.

What is Adagio Therapeutics's EPS forecast for next year?

Adagio Therapeutics's earnings are expected to grow from ($2.27) per share to ($1.87) per share in the next year.

More Earnings Resources from MarketBeat

Earnings Tools:
Earnings By Country:
Latest Articles:
Upcoming Earnings:
This page (NASDAQ:ADGI) was last updated on 11/29/2022 by MarketBeat.com Staff